VerbatimParliament, as it happens

Liothyronine

Asked by Anna SabineLiberal DemocratDepartment of Health and Social CareTabled Answered 17 December 2025UIN 98244

The question

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that NHSE informs ICBs, practitioners and Regional Pharmacists about amendments to the liothyronine (T3) section in the guidance document entitled Items which should not routinely be prescribed in primary care.

Answered by Dr Zubir Ahmed

Regional chief pharmacists have been informed of the changes made to the liothyronine section, including Armour Thyroid and liothyronine combination products, of the ‘items that should not be prescribed in primary care’ policy guidance via email. They have been asked to cascade this information through their integrated care board’s regional networks.

Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →

Open this question in Verbatim →

Every written question, searchable

155,000 questions tabled since the election, with the answer each department gave — and the ones still unanswered, with the clock running. Free to search.

Search written questions →Read on Verbatim